These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 24135651)
1. Methods for site-specific drug conjugation to antibodies. Behrens CR; Liu B MAbs; 2014; 6(1):46-53. PubMed ID: 24135651 [TBL] [Abstract][Full Text] [Related]
2. Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs. Behrens CR; Ha EH; Chinn LL; Bowers S; Probst G; Fitch-Bruhns M; Monteon J; Valdiosera A; Bermudez A; Liao-Chan S; Wong T; Melnick J; Theunissen JW; Flory MR; Houser D; Venstrom K; Levashova Z; Sauer P; Migone TS; van der Horst EH; Halcomb RL; Jackson DY Mol Pharm; 2015 Nov; 12(11):3986-98. PubMed ID: 26393951 [TBL] [Abstract][Full Text] [Related]
3. [Advances in the study of site-specific antibody-drug conjugates]. Sun Y; Huang R; Sun BW Yao Xue Xue Bao; 2015 Oct; 50(10):1225-31. PubMed ID: 26837166 [TBL] [Abstract][Full Text] [Related]
4. Advances in the Development of Site-Specific Antibody-Drug Conjugation. Zhou Q; Kim J Anticancer Agents Med Chem; 2015; 15(7):828-36. PubMed ID: 25731178 [TBL] [Abstract][Full Text] [Related]
5. Antibody-drug conjugates: recent advances in conjugation and linker chemistries. Tsuchikama K; An Z Protein Cell; 2018 Jan; 9(1):33-46. PubMed ID: 27743348 [TBL] [Abstract][Full Text] [Related]
6. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates. Yamada K; Ito Y Chembiochem; 2019 Nov; 20(21):2729-2737. PubMed ID: 30973187 [TBL] [Abstract][Full Text] [Related]
7. [Novel Chemical Linkers for Next-generation Antibody-drug Conjugates(ADCs)]. Tsuchikama K Yakugaku Zasshi; 2019; 139(2):209-219. PubMed ID: 30713230 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of cysteine and site specific conjugated herceptin antibody-drug conjugates. Jackson D; Atkinson J; Guevara CI; Zhang C; Kery V; Moon SJ; Virata C; Yang P; Lowe C; Pinkstaff J; Cho H; Knudsen N; Manibusan A; Tian F; Sun Y; Lu Y; Sellers A; Jia XC; Joseph I; Anand B; Morrison K; Pereira DS; Stover D PLoS One; 2014; 9(1):e83865. PubMed ID: 24454709 [TBL] [Abstract][Full Text] [Related]
9. Site-specific antibody drug conjugates for cancer therapy. Panowski S; Bhakta S; Raab H; Polakis P; Junutula JR MAbs; 2014; 6(1):34-45. PubMed ID: 24423619 [TBL] [Abstract][Full Text] [Related]
10. Site-Specific Conjugation of the Indolinobenzodiazepine DGN549 to Antibodies Affords Antibody-Drug Conjugates with an Improved Therapeutic Index as Compared with Lysine Conjugation. Bai C; Reid EE; Wilhelm A; Shizuka M; Maloney EK; Laleau R; Harvey L; Archer KE; Vitharana D; Adams S; Kovtun Y; Miller ML; Chari R; Keating TA; Yoder NC Bioconjug Chem; 2020 Jan; 31(1):93-103. PubMed ID: 31747250 [TBL] [Abstract][Full Text] [Related]
11. Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugates. Strop P; Liu SH; Dorywalska M; Delaria K; Dushin RG; Tran TT; Ho WH; Farias S; Casas MG; Abdiche Y; Zhou D; Chandrasekaran R; Samain C; Loo C; Rossi A; Rickert M; Krimm S; Wong T; Chin SM; Yu J; Dilley J; Chaparro-Riggers J; Filzen GF; O'Donnell CJ; Wang F; Myers JS; Pons J; Shelton DL; Rajpal A Chem Biol; 2013 Feb; 20(2):161-7. PubMed ID: 23438745 [TBL] [Abstract][Full Text] [Related]
12. Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors. Lütje S; Gerrits D; Molkenboer-Kuenen JD; Herrmann K; Fracasso G; Colombatti M; Boerman OC; Heskamp S J Nucl Med; 2018 Mar; 59(3):494-501. PubMed ID: 29146698 [TBL] [Abstract][Full Text] [Related]
13. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics. Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768 [TBL] [Abstract][Full Text] [Related]
14. Current methods for the synthesis of homogeneous antibody-drug conjugates. Sochaj AM; Świderska KW; Otlewski J Biotechnol Adv; 2015 Nov; 33(6 Pt 1):775-84. PubMed ID: 25981886 [TBL] [Abstract][Full Text] [Related]
15. A Case Study Comparing Heterogeneous Lysine- and Site-Specific Cysteine-Conjugated Maytansinoid Antibody-Drug Conjugates (ADCs) Illustrates the Benefits of Lysine Conjugation. Yoder NC; Bai C; Tavares D; Widdison WC; Whiteman KR; Wilhelm A; Wilhelm SD; McShea MA; Maloney EK; Ab O; Wang L; Jin S; Erickson HK; Keating TA; Lambert JM Mol Pharm; 2019 Sep; 16(9):3926-3937. PubMed ID: 31287952 [TBL] [Abstract][Full Text] [Related]
16. Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy. Chen H; Lin Z; Arnst KE; Miller DD; Li W Molecules; 2017 Aug; 22(8):. PubMed ID: 28763044 [TBL] [Abstract][Full Text] [Related]
17. Antibody drug conjugates. Bakhtiar R Biotechnol Lett; 2016 Oct; 38(10):1655-64. PubMed ID: 27334710 [TBL] [Abstract][Full Text] [Related]
19. Conjugation Site Analysis of Lysine-Conjugated ADCs. Sang H; Wan N; Lu G; Tian Y; Wang G; Ye H Methods Mol Biol; 2020; 2078():235-250. PubMed ID: 31643061 [TBL] [Abstract][Full Text] [Related]
20. Site-Specific Conjugation of Monomethyl Auristatin E to Anti-CD30 Antibodies Improves Their Pharmacokinetics and Therapeutic Index in Rodent Models. Lhospice F; Brégeon D; Belmant C; Dennler P; Chiotellis A; Fischer E; Gauthier L; Boëdec A; Rispaud H; Savard-Chambard S; Represa A; Schneider N; Paturel C; Sapet M; Delcambre C; Ingoure S; Viaud N; Bonnafous C; Schibli R; Romagné F Mol Pharm; 2015 Jun; 12(6):1863-71. PubMed ID: 25625323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]